Fulcrum Therapeutics, Inc.
← Back to FULC Overview

Fulcrum Therapeutics, Inc. (FULC)

Profitability & Net Margin History

Current Net Margin

Fulcrum Therapeutics, Inc. currently has a net profit margin of .

Financial Fundamentals

FULCQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.02
2025-09-300.00-0.02
2025-06-300.00-0.02
2025-03-310.00-0.02
2024-12-310.00-0.02
2024-09-300.00-0.02
2024-06-300.080.0669.26%
2024-03-310.00-0.03
2023-12-310.00-0.02-2842.25%32204
2023-09-300.00-0.02-3164.30%46168
2023-06-300.00-0.02-2702.61%569705
2023-03-310.00-0.02-8399.66%458433
2022-12-310.00-0.03-3815.33%180874
2022-09-300.00-0.02-2006.59%19629
2022-06-300.00-0.03-1810.31%81000
2022-03-310.00-0.03-1000.31%53601
2021-12-310.01-0.02-464.29%4452
2021-09-300.00-0.02-419.78%2870
2021-06-300.00-0.02-448.48%9352
2021-03-310.00-0.02-354.96%6445
2020-12-310.00-0.02-419.41%60667
2020-09-300.00-0.02-1026.08%24183
2020-06-300.00-0.02-784.25%167602
2020-03-310.00-0.02-2460.27%
2019-12-310.00-0.02
2019-09-300.00-0.02
2019-06-300.00-0.01
2019-03-310.00-0.04
2018-12-310.00-0.01
2018-09-300.00-0.01
2018-06-300.00-0.01
2018-03-310.00-0.01

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.